NO20021475D0 - Vasopressinantagonist, formulering og fremgangsmåte - Google Patents

Vasopressinantagonist, formulering og fremgangsmåte

Info

Publication number
NO20021475D0
NO20021475D0 NO20021475A NO20021475A NO20021475D0 NO 20021475 D0 NO20021475 D0 NO 20021475D0 NO 20021475 A NO20021475 A NO 20021475A NO 20021475 A NO20021475 A NO 20021475A NO 20021475 D0 NO20021475 D0 NO 20021475D0
Authority
NO
Norway
Prior art keywords
formulation
vasopressin antagonist
vasopressin
antagonist
Prior art date
Application number
NO20021475A
Other languages
English (en)
Other versions
NO20021475L (no
Inventor
Joseph Kyuwung Yoon
Richard William Saunders
Mahdi Bakir Fawzi
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NO20021475D0 publication Critical patent/NO20021475D0/no
Publication of NO20021475L publication Critical patent/NO20021475L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20021475A 1999-09-27 2002-03-25 Vasopressinantagonist, formulering og fremgangsmåte NO20021475L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40577299A 1999-09-27 1999-09-27
PCT/US2000/026369 WO2001022945A1 (en) 1999-09-27 2000-09-26 Vasopressin antagonist formulation and process

Publications (2)

Publication Number Publication Date
NO20021475D0 true NO20021475D0 (no) 2002-03-25
NO20021475L NO20021475L (no) 2002-04-16

Family

ID=23605168

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021475A NO20021475L (no) 1999-09-27 2002-03-25 Vasopressinantagonist, formulering og fremgangsmåte

Country Status (18)

Country Link
EP (1) EP1216033A1 (no)
JP (1) JP2003510269A (no)
KR (1) KR20020039354A (no)
CN (1) CN1391466A (no)
AR (1) AR025780A1 (no)
AU (1) AU7615000A (no)
BR (1) BR0014351A (no)
CA (1) CA2388474A1 (no)
CZ (1) CZ20021083A3 (no)
EA (1) EA200200414A1 (no)
HK (1) HK1045109A1 (no)
HU (1) HUP0202972A3 (no)
IL (1) IL148541A0 (no)
MX (1) MXPA02003189A (no)
NO (1) NO20021475L (no)
PL (1) PL354282A1 (no)
WO (1) WO2001022945A1 (no)
ZA (1) ZA200203312B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030105144A1 (en) * 2001-04-17 2003-06-05 Ping Gao Stabilized oral pharmaceutical composition
WO2003072085A1 (fr) * 2002-02-27 2003-09-04 Shionogi & Co., Ltd. Preparations solides contenant un medicament a peine soluble dans l'eau d'une meilleure absorbabilite
JP5873375B2 (ja) * 2012-04-03 2016-03-01 中日本カプセル 株式会社 ソフトカプセル及びソフトカプセルの製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516774A (en) * 1993-07-29 1996-05-14 American Cyanamid Company Tricyclic diazepine vasopressin antagonists and oxytocin antagonists
ATE429210T1 (de) * 1998-01-20 2009-05-15 Applied Analytical Ind Inc Orale flüssige zusammensetzungen

Also Published As

Publication number Publication date
EA200200414A1 (ru) 2002-12-26
HUP0202972A3 (en) 2003-07-28
PL354282A1 (en) 2003-12-29
MXPA02003189A (es) 2002-09-30
CN1391466A (zh) 2003-01-15
HUP0202972A2 (hu) 2002-12-28
IL148541A0 (en) 2002-09-12
ZA200203312B (en) 2003-12-31
AR025780A1 (es) 2002-12-11
BR0014351A (pt) 2002-06-11
AU7615000A (en) 2001-04-30
EP1216033A1 (en) 2002-06-26
KR20020039354A (ko) 2002-05-25
CA2388474A1 (en) 2001-04-05
CZ20021083A3 (cs) 2002-06-12
WO2001022945A1 (en) 2001-04-05
NO20021475L (no) 2002-04-16
JP2003510269A (ja) 2003-03-18
HK1045109A1 (zh) 2002-11-15

Similar Documents

Publication Publication Date Title
NO20022086D0 (no) Antidiabetisk formulering og fremgangsmåte
NO20013393D0 (no) Brönnsementeringsfremgangsmåter og sammensetninger
NO20012567D0 (no) Azepinoindolderivater, fremstilling og anvendelse derav
NO20021379D0 (no) Benzodiazepin-derivater, fremstilling og anvendelse derav
NO20023216D0 (no) Instrumentert sementeringsplugg og system for samme
NO2010019I2 (no) 6-per-deoksy-6-per-(2-karboksetyl)tio-y-cyklodextrin
DK1180518T3 (da) 5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf
DE60031119D1 (de) Richtbohrvorrichtung und -verfahren
DE60026169D1 (de) Selektive neurokinin-antagonisten
DK1339292T3 (da) Sammensætning og fremgangsmåde
DE50010609D1 (de) Sport-trainings-vorrichtung sowie sport-trainings-system
DK1261697T3 (da) Kuldeaktiv beta-galactosidase, fremgangsmåde til fremstilling heraf og anvendelsen deraf
NO990431D0 (no) Golfk°llehode
DK1275397T3 (da) Lægemiddel til lokal anvendelse
NO990243D0 (no) Trovafloxacin-mesylat-tablett
DE60022999D1 (de) Bradykinin receptorantagoniste
MXPA03003796A (es) Procedimiento y dispositivos de aplicacion por vertido.
NO20014088D0 (no) Varmebeskyttet gjennomforing
NO20005763L (no) DHEA-sammensetning og fremgangsmåte
ITMI991977A0 (it) Apparecchiatura incappucciatrice combinata
NO20021475D0 (no) Vasopressinantagonist, formulering og fremgangsmåte
DE50009171D1 (de) Co 2 - kompressor
DE60041297D1 (de) Empfangsgerät und- Verfahren
GB0009326D0 (en) Access scaffolding, scaffolding devices and method
DE50001571D1 (de) Stehhilfe

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application